•
Jun 30, 2018

Corcept Therapeutics Q2 2018 Earnings Report

Total Revenue
$62.3M
Previous year: $35.6M
+75.2%
EPS
$0.2
Previous year: $0.13
+53.8%
Gross Profit
$61.2M
Previous year: $34.8M
+75.8%
Cash and Equivalents
$31.2M
Previous year: $33.6M
-7.3%
Free Cash Flow
$15.1M
Previous year: $24.9M
-39.2%
Total Assets
$274M
Previous year: $86.5M
+217.1%

Corcept Therapeutics

Corcept Therapeutics